352 related articles for article (PubMed ID: 10933057)
1. Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase.
Murakami K; Sakukawa R; Ikeda T; Matsuura T; Hasumura S; Nagamori S; Yamada Y; Saiki I
Neoplasia; 1999 Nov; 1(5):424-30. PubMed ID: 10933057
[TBL] [Abstract][Full Text] [Related]
2. Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells.
Monvoisin A; Bisson C; Si-Tayeb K; Balabaud C; Desmoulière A; Rosenbaum J
Int J Cancer; 2002 Jan; 97(2):157-62. PubMed ID: 11774258
[TBL] [Abstract][Full Text] [Related]
3. Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) on prostate cancer cell lines.
Nagakawa O; Murakami K; Yamaura T; Fujiuchi Y; Murata J; Fuse H; Saiki I
Cancer Lett; 2000 Jul; 155(2):173-9. PubMed ID: 10822133
[TBL] [Abstract][Full Text] [Related]
4. Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion.
Giannelli G; Bergamini C; Fransvea E; Marinosci F; Quaranta V; Antonaci S
Lab Invest; 2001 Apr; 81(4):613-27. PubMed ID: 11304581
[TBL] [Abstract][Full Text] [Related]
5. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
[TBL] [Abstract][Full Text] [Related]
6. Inhibition and mechanism of action of a protease inhibitor in human pancreatic cancer cells.
Uchima Y; Sawada T; Nishihara T; Maeda K; Ohira M; Hirakawa K
Pancreas; 2004 Aug; 29(2):123-31. PubMed ID: 15257104
[TBL] [Abstract][Full Text] [Related]
7. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.
Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S
Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608
[TBL] [Abstract][Full Text] [Related]
8. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.
Xie Z; Yuan H; Yin Y; Zeng X; Bai R; Glazer RI
BMC Cancer; 2006 Mar; 6():77. PubMed ID: 16551362
[TBL] [Abstract][Full Text] [Related]
9. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of metastasis by membrane type 1-matrix metalloproteinase in hepatocellular carcinoma.
Ip YC; Cheung ST; Leung KL; Fan ST
World J Gastroenterol; 2005 Oct; 11(40):6269-76. PubMed ID: 16419154
[TBL] [Abstract][Full Text] [Related]
11. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling.
Zhang D; Brodt P
Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384
[TBL] [Abstract][Full Text] [Related]
12. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS
Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544
[TBL] [Abstract][Full Text] [Related]
13. [The role of membrane-type 1 matrix metalloproteinase in the invasion and metastasis of hepatocellular carcinoma].
Cai Y; Wu Z; Fan J; Feng G; He B; Liu Y; Ye S; Tang Z
Zhonghua Gan Zang Bing Za Zhi; 2000 Aug; 8(4):236-8. PubMed ID: 10951628
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases.
Harvey P; Clark IM; Jaurand MC; Warn RM; Edwards DR
Br J Cancer; 2000 Nov; 83(9):1147-53. PubMed ID: 11027427
[TBL] [Abstract][Full Text] [Related]
15. Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth.
Iida J; Wilhelmson KL; Price MA; Wilson CM; Pei D; Furcht LT; McCarthy JB
J Invest Dermatol; 2004 Jan; 122(1):167-76. PubMed ID: 14962105
[TBL] [Abstract][Full Text] [Related]
16. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells.
Fishman DA; Bafetti LM; Stack MS
Invasion Metastasis; 1996; 16(3):150-9. PubMed ID: 9186550
[TBL] [Abstract][Full Text] [Related]
17. Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain.
Lehti K; Valtanen H; Wickström SA; Lohi J; Keski-Oja J
J Biol Chem; 2000 May; 275(20):15006-13. PubMed ID: 10748199
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines.
Heikkilä P; Teronen O; Moilanen M; Konttinen YT; Hanemaaijer R; Laitinen M; Maisi P; van der Pluijm G; Bartlett JD; Salo T; Sorsa T
Anticancer Drugs; 2002 Mar; 13(3):245-54. PubMed ID: 11984068
[TBL] [Abstract][Full Text] [Related]
19. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
20. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP.
Hamasuna R; Kataoka H; Moriyama T; Itoh H; Seiki M; Koono M
Int J Cancer; 1999 Jul; 82(2):274-81. PubMed ID: 10389763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
